Deferasirox selectively induces cell death in the clinically relevant population of leukemic CD34 + CD38 – cells through iron chelation, induction of ROS, and inhibition of HIF1α expression

Saar Shapira, Pia Raanani, Aladin Samara, Arnon Nagler, Ido Lubin, Nadir Arber, Galit Granot*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Deferasirox selectively induces cell death in the clinically relevant population of leukemic CD34 + CD38 – cells through iron chelation, induction of ROS, and inhibition of HIF1α expression'. Together they form a unique fingerprint.

Medicine & Life Sciences